Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2015, Article ID 746563, 5 pages
http://dx.doi.org/10.1155/2015/746563
Research Article

Factors Associated with Uncontrolled Hypertension among Renal Transplant Recipients Attending Nephrology Clinics in Nairobi, Kenya

1Department of Clinical Medicine and Therapeutics, University of Nairobi (UoN), P.O. Box 60337-00200, Nairobi, Kenya
2Kenyatta National Hospital (KNH), Nairobi, Kenya

Received 25 March 2015; Revised 6 June 2015; Accepted 1 July 2015

Academic Editor: Gaetano Ciancio

Copyright © 2015 Mary N. Kubo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. L. Kasiske, S. Anjum, R. Shah et al., “Hypertension after kidney transplantation,” American Journal of Kidney Diseases, vol. 43, no. 6, pp. 1071–1081, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Morales, A. Andres, M. Rengel, and J. L. Rodicio, “Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation,” Nephrology Dialysis Transplantation, vol. 16, no. 1, pp. 121–124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Kasiske, M. Zeier, J. Chapman et al., “KDIGO clinical practice guideline for the care of kidney transplant recipients,” American Journal of Transplantation, vol. 9, supplement 3, pp. S71–S79, 2009. View at Google Scholar
  4. J. Mason, F. Kleemann, J. Bankart, J. Medcalf, and S. Carr, “Blood pressure in renal transplant recipients: are there independent predictors for achieving target blood pressure?” Nephron—Clinical Practice, vol. 111, no. 3, pp. c159–c166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Vella and G. Danovitch, “Transplantation nephrology self-assessment program,” Transplantation, vol. 7, pp. 1–12, 2008. View at Google Scholar
  6. G. Opelz, T. Wujciak, and E. Ritz, “Association of chronic kidney graft failure with recipient blood pressure,” Kidney International, vol. 53, no. 1, pp. 217–222, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. World Health Organization (WHO), Adherence to Long-Term Therapies: Evidence for Action, WHO, Geneva, Switzerland, 2003.
  8. A. D. Oliveira-Filho, J. A. Barreto-Filho, S. J. F. Neves, and D. P. de Lyra Jr., “Association between the 8-item Morisky Medication adherence Scale (MMAS-8) and blood pressure control,” Arquivos Brasileiros de Cardiologia, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Terebelo and M. Markell, “Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients,” Transplantation Proceedings, vol. 42, no. 9, pp. 3578–3585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Bulatova, A.-M. Yousef, H. Qusa et al., “Management of hypertension and factors affecting its control in Jordanian renal transplant recipients,” International Journal of Clinical Pharmacy, vol. 34, no. 3, pp. 439–444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Mason, F. Kleemann, J. Bankart, J. Medcalf, and S. Carr, “Blood pressure in renal transplant recipients: are there independent predictors for achieving target blood pressure?” Nephron: Clinical Practice, vol. 111, no. 3, pp. c159–c166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Beltrán, J. Crespo, J. Kanter et al., “Ambulatory blood pressure monitoring in renal transplant patients: should it be routinely performed?” Transplantation Proceedings, vol. 42, no. 8, pp. 2868–2870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bohlke, F. C. Barcellos, M. Rocha, R. H. Gomes, L. Terhorst, and S. S. Marini, “Predictors of hypertension following successful renal transplantation: a population-based survey,” Transplantation Proceedings, vol. 41, no. 9, pp. 3743–3746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. T. G. Pickering, J. E. Hall, L. J. Appel et al., “AHA scientific statement: recommendations for blood pressure measurement in humans and experimental animals,” Hypertension, vol. 45, pp. 142–161, 2005. View at Publisher · View at Google Scholar
  15. WHO, Physical Status: the Use and Interpretation of Anthropometry. Report of a WHO Expert Committee, WHO Technical Report Series 854, World Health Organization, Geneva, Switzerland, 1995.
  16. D. E. Morisky, A. Ang, M. Krousel-Wood, and H. J. Ward, “Predictive validity of a medication adherence measure in an outpatient setting,” Journal of Clinical Hypertension, vol. 10, no. 5, pp. 348–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Barsoum, “End-stage renal disease in North Africa,” Kidney International. Supplement, vol. 63, no. 83, pp. S111–S114, 2003. View at Google Scholar · View at Scopus
  18. L. Achieng', M. D. Joshi, E. N. Ogola, and E. Karari, “Adequacy of blood pressure control and level of adherence with antihypertensive therapy,” East African Medical Journal, vol. 86, no. 11, pp. 499–506, 2009. View at Google Scholar · View at Scopus
  19. J. D. Piette, A. M. Rosland, M. J. Silveira, R. Hayward, and C. A. McHorney, “Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse?” Patient Preference and Adherence, vol. 5, pp. 187–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Taira, K. S. Wong, F. Frech-Tamas, and R. S. Chung, “Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care,” The American Journal of Managed Care, vol. 12, no. 11, pp. 678–683, 2006. View at Google Scholar · View at Scopus
  21. D. J. Hyman and V. N. Pavlik, “Characteristics of patients with uncontrolled hypertension in the United States,” The New England Journal of Medicine, vol. 345, no. 7, pp. 479–486, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Reckelhoff, “Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations,” Hypertension, vol. 45, no. 2, pp. 170–174, 2005. View at Publisher · View at Google Scholar · View at Scopus